21.50
price up icon1.56%   0.33
after-market アフターアワーズ: 21.52 0.02 +0.09%
loading
前日終値:
$21.17
開ける:
$21.17
24時間の取引高:
124.92K
Relative Volume:
1.48
時価総額:
$287.73M
収益:
$116.26M
当期純損益:
$-11.08M
株価収益率:
-27.16
EPS:
-0.7917
ネットキャッシュフロー:
$1.04M
1週間 パフォーマンス:
+0.37%
1か月 パフォーマンス:
+38.53%
6か月 パフォーマンス:
+110.58%
1年 パフォーマンス:
+148.84%
1日の値動き範囲:
Value
$21.04
$21.98
1週間の範囲:
Value
$20.42
$22.88
52週間の値動き範囲:
Value
$8.2205
$22.88

Anika Therapeutics Inc Stock (ANIK) Company Profile

Name
名前
Anika Therapeutics Inc
Name
セクター
Healthcare (1080)
Name
電話
(781) 457-9000
Name
住所
32 WIGGINS AVENUE, BEDFORD, MA
Name
職員
235
Name
Twitter
Name
次回の収益日
2026-07-29
Name
最新のSEC提出書
Name
ANIK's Discussions on Twitter

Compare ANIK vs TAK, TEVA, HLN, ZTS, UTHR

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
ANIK icon
ANIK
Anika Therapeutics Inc
21.50 294.83M 116.26M -11.08M 1.04M -0.7917
TAK icon
TAK
Takeda Pharmaceutical Co Adr
17.63 55.60B 29.91B 1.30B 3.49B 0.4056
TEVA icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
36.77 42.81B 17.53B 1.58B 444.18M 1.3457
HLN icon
HLN
Haleon Plc Adr
9.70 43.16B 14.54B 2.22B 2.58B 0.4871
ZTS icon
ZTS
Zoetis Inc
73.79 30.39B 9.51B 2.64B 2.14B 6.0361
UTHR icon
UTHR
United Therapeutics Corp
499.73 21.95B 3.17B 1.29B 1.01B 27.09

Anika Therapeutics Inc Stock (ANIK) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-17 開始されました B. Riley Securities Buy
2024-11-01 繰り返されました Barrington Research Outperform
2023-08-14 アップグレード Barrington Research Mkt Perform → Outperform
2023-03-07 ダウングレード Barrington Research Outperform → Mkt Perform
2022-11-09 アップグレード Barrington Research Mkt Perform → Outperform
2022-10-14 再開されました Stephens Equal-Weight
2022-03-09 ダウングレード Barrington Research Outperform → Mkt Perform
2022-03-09 ダウングレード Stephens Overweight → Equal-Weight
2021-11-16 開始されました Stephens Overweight
2021-07-16 開始されました UBS Neutral
2020-12-16 アップグレード Barrington Research Mkt Perform → Outperform
2020-05-08 ダウングレード Barrington Research Outperform → Mkt Perform
2020-01-21 アップグレード Sidoti Neutral → Buy
2020-01-10 アップグレード First Analysis Sec Outperform → Strong Buy
2019-11-05 開始されました BWS Financial Sell
2019-09-24 繰り返されました Barrington Research Outperform
2019-09-23 ダウングレード First Analysis Sec Strong Buy → Outperform
2019-07-25 アップグレード First Analysis Sec Neutral → Strong Buy
2019-02-22 ダウングレード First Analysis Sec Outperform → Neutral
2019-02-22 ダウングレード Sidoti Buy → Neutral
2018-07-27 アップグレード Barrington Research Mkt Perform → Outperform
2018-06-20 ダウングレード Barrington Research Outperform → Mkt Perform
2018-06-20 ダウングレード First Analysis Sec Overweight → Equal-Weight
2018-05-04 アップグレード Barrington Research Mkt Perform → Outperform
2018-02-23 ダウングレード Barrington Research Outperform → Mkt Perform
2018-01-24 アップグレード First Analysis Sec Equal-Weight → Overweight
2017-10-27 繰り返されました Barrington Research Outperform
2016-05-09 アップグレード Singular Research BUY - Long-Term → Buy
2016-04-27 ダウングレード Northland Capital Outperform → Market Perform
2016-02-26 繰り返されました Barrington Research Outperform
すべてを表示

Anika Therapeutics Inc (ANIK) 最新ニュース

pulisher
Aug 14, 2026

Anika Therapeutics (ANIK) Is Up 11.10% in One Week: What You Should Know - Yahoo Finance

Aug 14, 2026
pulisher
Aug 13, 2026

Anika Therapeutics, Inc. (ANIK) stock price, news, quote and history - Yahoo Finance Singapore

Aug 13, 2026
pulisher
Aug 12, 2026

Anika Therapeutics Inc (ANIK) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Aug 12, 2026
pulisher
Aug 11, 2026

Zacks.com featured highlights include OptimumBank, EuroDry, Enova International, Anika Therapeutics and The GEO - Yahoo Finance

Aug 11, 2026
pulisher
Aug 08, 2026

Understanding Momentum Shifts in (ANIK) - Stock Traders Daily

Aug 08, 2026
pulisher
Aug 07, 2026

ANIK (NASDAQ: ANIK) holder plans Form 144 sale of 16,864 shares - Stock Titan

Aug 07, 2026
pulisher
Aug 07, 2026

Anika (ANIK) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance

Aug 07, 2026
pulisher
Aug 07, 2026

Anika Therapeutics (NASDAQ:ANIK) Raised to Strong-Buy at Zacks Research - MarketBeat

Aug 07, 2026
pulisher
Aug 06, 2026

Anika Therapeutics (ANIK) Insider Gary Fischetti Buys 2,000 Shar - GuruFocus

Aug 06, 2026
pulisher
Aug 05, 2026

Anika Therapeutics (NASDAQ:ANIK) Director Purchases 1,000 Shares - MarketBeat

Aug 05, 2026
pulisher
Aug 05, 2026

Anika Therapeutics (ANIK) director purchases 2,000 common shares in market buys - Stock Titan

Aug 05, 2026
pulisher
Aug 05, 2026

Anika Therapeutics (ANIK) Dips 2.14% to $19.19 as Support Level Comes into FocusLiquidity Sweep - dars.gov.et

Aug 05, 2026
pulisher
Aug 05, 2026

Anika Therapeutics Lifts Outlook After Margin Surge - TipRanks

Aug 05, 2026
pulisher
Aug 04, 2026

Q1 2025 Anika Therapeutics Inc Earnings Call Transcript - GuruFocus

Aug 04, 2026
pulisher
Aug 02, 2026

Anika Therapeutics (ANIK) Stock Fair Value Rises After Q2 Beat And Higher Guidance - Yahoo Finance

Aug 02, 2026
pulisher
Aug 01, 2026

Anika Therapeutics Gains 29%, Insider Trades Reap Benefit - Moomoo

Aug 01, 2026
pulisher
Aug 01, 2026

Wall Street Zen Upgrades Anika Therapeutics (NASDAQ:ANIK) to Strong-Buy - marketbeat.com

Aug 01, 2026
pulisher
Jul 31, 2026

Anika Therapeutics expands Integrity implant reach with 3,300 U.S. procedures and international availability - Traders Union

Jul 31, 2026
pulisher
Jul 31, 2026

Vanguard Capital Management (ANIK) discloses 4.95% beneficial stake in Anika Therapeutics - Stock Titan

Jul 31, 2026
pulisher
Jul 30, 2026

B. Riley Adjusts Anika Therapeutics Price Target to $21 From $18, Maintains Buy Rating - Moomoo

Jul 30, 2026
pulisher
Jul 30, 2026

B. Riley Securities Maintains Anika Therapeutics(ANIK.US) With Buy Rating, Raises Target Price to $21 - Moomoo

Jul 30, 2026
pulisher
Jul 30, 2026

These 2 Biotech Stocks Hit New 52-Week Highs Today – And CORT Clocked Its Best Day In Nearly 16 Months - Stocktwits

Jul 30, 2026
pulisher
Jul 29, 2026

Anika Therapeutics Q2 2026 slides: margins surge, guidance raised By Investing.com - Investing.com Nigeria

Jul 29, 2026
pulisher
Jul 29, 2026

Anika Therapeutics Inc (ANIK) Q2 2026 Earnings Call Highlights: - GuruFocus

Jul 29, 2026
pulisher
Jul 29, 2026

Is Anika Therapeutics Inc (ANIK) On The Rise After Q2 Earnings B - GuruFocus

Jul 29, 2026
pulisher
Jul 29, 2026

Transcript : Anika Therapeutics, Inc., Q2 2026 Earnings Call, Jul 29, 2026 - marketscreener.com

Jul 29, 2026
pulisher
Jul 29, 2026

Anika Therapeutics Q2 revenue rises 16% to $32.6 million - Quiver Quantitative

Jul 29, 2026
pulisher
Jul 29, 2026

Anika: Q2 Earnings Snapshot - KING5.com

Jul 29, 2026
pulisher
Jul 29, 2026

BRIEF-Anika Therapeutics Q2 Revenue USD 32.61 Million - TradingView

Jul 29, 2026
pulisher
Jul 28, 2026

ANIK|Anika Therapeutics Inc|Price:15.010|Chg%:+0.060 - TradingKey

Jul 28, 2026
pulisher
Jul 27, 2026

Anika Therapeutics Inc (ANIK) Balance Sheet - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Anika Therapeutics Inc (ANIK) Income Statement - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Anika Therapeutics Inc (ANIK) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

ANIK|Anika Therapeutics Inc|Price:15.030|Chg%:+0.010 - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Anika Therapeutics Inc (ANIK) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Anika Therapeutics Inc (ANIK) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Anika Therapeutics Inc (ANIK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Anika Therapeutics Inc (ANIK) Cash Flow - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Anika Therapeutics Inc expected to post a loss of 8 cents a shareEarnings Preview - TradingView

Jul 27, 2026
pulisher
Jul 25, 2026

Anika Therapeutics, Inc. Revenue Breakdown – BX:AKP - TradingView

Jul 25, 2026
pulisher
Jul 24, 2026

Anika Therapeutics Inc (ANIK) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jul 24, 2026
pulisher
Jul 23, 2026

Anika Therapeutics Q1 2026 Earnings: Strong EPS Beat Driven by Operational EfficienciesFree Cash Flow Trends - dars.gov.et

Jul 23, 2026
pulisher
Jul 23, 2026

Anika Therapeutics (ANIK) 2026 CG Musculoskeletal Conference Summary - Quartr

Jul 23, 2026
pulisher
Jul 22, 2026

Anika Therapeutics (ANIK) Proxy filing Summary - Quartr

Jul 22, 2026
pulisher
Jul 22, 2026

Anika Therapeutics (ANIK) Q4 2025 earnings summary - Quartr

Jul 22, 2026
pulisher
Jul 22, 2026

Anika Therapeutics (ANIK) AGM 2026 Summary - Quartr

Jul 22, 2026
pulisher
Jul 22, 2026

Anika Therapeutics (ANIK) Expected to Post Earnings on Wednesday - MarketBeat

Jul 22, 2026
pulisher
Jul 17, 2026

BlackRock Portfolio Management (NASDAQ: ANIK) discloses 4.1% Anika Therapeutics ownership - Stock Titan

Jul 17, 2026
pulisher
Jul 16, 2026

Discipline and Rules-Based Execution in ANIK Response - Stock Traders Daily

Jul 16, 2026
pulisher
Jul 16, 2026

Anika Therapeutics Expands Revolving Credit Facility Agreement - The Globe and Mail

Jul 16, 2026
pulisher
Jul 16, 2026

Anika to Issue Second Quarter 2026 Financial Results on Wednesday, July 29, 2026 - The Manila Times

Jul 16, 2026

Anika Therapeutics Inc (ANIK) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$49.06
price down icon 0.79%
RDY RDY
$12.27
price down icon 1.21%
$23.67
price up icon 5.15%
$152.72
price up icon 1.26%
$16.23
price up icon 1.18%
$499.73
price down icon 0.31%
大文字化:     |  ボリューム (24 時間):